IMMUNIC INC's ticker is IMUX and the CUSIP is 4525EP101. A total of 56 filers reported holding IMMUNIC INC in Q3 2023. The put-call ratio across all filers is 15.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $47,178 | -67.1% | 32,094 | -43.8% | 0.00% | – |
Q2 2023 | $143,334 | -81.7% | 57,105 | -89.1% | 0.00% | – |
Q1 2023 | $781,468 | +17.7% | 524,475 | +10.6% | 0.00% | – |
Q4 2022 | $664,127 | +1085.9% | 474,377 | +2552.4% | 0.00% | – |
Q3 2022 | $56,000 | -58.8% | 17,885 | -54.4% | 0.00% | – |
Q2 2022 | $136,000 | -49.4% | 39,237 | +64.8% | 0.00% | – |
Q1 2022 | $269,000 | -52.6% | 23,810 | -59.8% | 0.00% | – |
Q4 2021 | $567,000 | +496.8% | 59,218 | +449.1% | 0.00% | – |
Q3 2021 | $95,000 | -12.0% | 10,785 | +23.1% | 0.00% | – |
Q2 2021 | $108,000 | +10700.0% | 8,762 | +14032.3% | 0.00% | – |
Q1 2021 | $1,000 | -98.4% | 62 | -98.5% | 0.00% | – |
Q4 2020 | $64,000 | +392.3% | 4,179 | +503.9% | 0.00% | – |
Q3 2020 | $13,000 | -7.1% | 692 | -40.8% | 0.00% | – |
Q2 2020 | $14,000 | +1300.0% | 1,168 | +694.6% | 0.00% | – |
Q1 2020 | $1,000 | 0.0% | 147 | 0.0% | 0.00% | – |
Q4 2019 | $1,000 | 0.0% | 147 | -0.7% | 0.00% | – |
Q3 2019 | $1,000 | -66.7% | 148 | -40.6% | 0.00% | – |
Q2 2019 | $3,000 | – | 249 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Omega Fund Management, LLC | 1,788,160 | $2,628,595 | 2.41% |
Gratus Capital, LLC | 1,686,455 | $2,479,089 | 0.17% |
INNOVIS ASSET MANAGEMENT LLC | 272,457 | $400,512 | 0.15% |
Parkman Healthcare Partners LLC | 562,506 | $826,884 | 0.15% |
RTW INVESTMENTS, LP | 4,335,255 | $6,372,825 | 0.13% |
Logos Global Management LP | 421,184 | $619,140 | 0.08% |
Ikarian Capital, LLC | 450,000 | $661,501 | 0.08% |
BVF INC/IL | 1,149,425 | $1,689,655 | 0.05% |
Soleus Capital Management, L.P. | 300,000 | $441,000 | 0.04% |
COWEN AND COMPANY, LLC | 317,059 | $466,076 | 0.03% |